Catherine Poole's Archive

Working Together to Help Melanoma Patients Globally

The Melanoma International Foundation hit the road recently for two important melanoma meetings in Boston. The first was the 2016 Global Coalition for Melanoma Patient Advocacy. The Melanoma Research Foundation […]

concierge

MIF: Your Concierge for the Melanoma Journey

Have you ever traveled to a large city or foreign country that you’ve never been to before? It can often feel overwhelming as sights, sounds and smells engulf your senses. […]

image-02-large

Do No Harm

Before becoming a doctor, medical students must take the Hippocratic Oath. The initial statement of the oath is: “First, do no harm.” As a patient navigator, I also take this […]

7064951511_f17f31ce21_o

Being Resilient

When someone is diagnosed or taking care of someone with a potentially deadly disease, such as melanoma, it may come with other things going wrong in life. Perhaps you are […]

September 02, 2016 | | 0 Comments

June 13, 2016: ASCO Update on Melanoma Therapy & More

Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the NCCN […]

February 8, 2016: Keytruda & Opdivo Queries

Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the NCCN […]

December 8, 2015: BRAF/MEK Therapy

Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the NCCN […]

October 19, 2015: Melanoma Stage III Decisions

  Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the […]

CampoTornado_WilloughbyOwen

Warrior or Weatherers? How Best to Deal with Melanoma Cancer

I’ve always been sensitive to the wording used casually to describe cancer patients. No matter the disease, it seems like others and the media put undue pressure on patients to […]

September 1, 2015: Blood Test & Other Diagnostics as Markers of Disease Progession

  Richard Joseph, MD, is an assistant professor of medicine/oncology at Mayo Clinic. His Hematology/Oncology fellowship was completed at MD Anderson Cancer Center. He is a voting member of the […]